BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37624574)

  • 21. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
    Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
    Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
    Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
    Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in SCF ubiquitin ligase complex: Clinical implications.
    Zheng N; Zhou Q; Wang Z; Wei W
    Biochim Biophys Acta; 2016 Aug; 1866(1):12-22. PubMed ID: 27156687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
    Biswas M; Phan D; Watanabe M; Chan JY
    J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The two faces of FBW7 in cancer drug resistance.
    Wang Z; Fukushima H; Gao D; Inuzuka H; Wan L; Lau AW; Liu P; Wei W
    Bioessays; 2011 Nov; 33(11):851-9. PubMed ID: 22006825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.
    Zheng N; Wang Z; Wei W
    Int J Biochem Cell Biol; 2016 Apr; 73():99-110. PubMed ID: 26860958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.
    Min SH; Lau AW; Lee TH; Inuzuka H; Wei S; Huang P; Shaik S; Lee DY; Finn G; Balastik M; Chen CH; Luo M; Tron AE; Decaprio JA; Zhou XZ; Wei W; Lu KP
    Mol Cell; 2012 Jun; 46(6):771-83. PubMed ID: 22608923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressor functions of FBW7 in cancer development and progression.
    Wang Z; Inuzuka H; Zhong J; Wan L; Fukushima H; Sarkar FH; Wei W
    FEBS Lett; 2012 May; 586(10):1409-18. PubMed ID: 22673505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12.
    Khan OM; Almagro J; Nelson JK; Horswell S; Encheva V; Keyan KS; Clurman BE; Snijders AP; Behrens A
    Nat Commun; 2021 Apr; 12(1):2043. PubMed ID: 33824312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
    Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
    Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
    Wertz IE; Kusam S; Lam C; Okamoto T; Sandoval W; Anderson DJ; Helgason E; Ernst JA; Eby M; Liu J; Belmont LD; Kaminker JS; O'Rourke KM; Pujara K; Kohli PB; Johnson AR; Chiu ML; Lill JR; Jackson PK; Fairbrother WJ; Seshagiri S; Ludlam MJ; Leong KG; Dueber EC; Maecker H; Huang DC; Dixit VM
    Nature; 2011 Mar; 471(7336):110-4. PubMed ID: 21368834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.
    Tong J; Tan S; Zou F; Yu J; Zhang L
    Oncogene; 2017 Feb; 36(6):787-796. PubMed ID: 27399335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.
    Suryo Rahmanto A; Savov V; Brunner A; Bolin S; Weishaupt H; Malyukova A; Rosén G; Čančer M; Hutter S; Sundström A; Kawauchi D; Jones DT; Spruck C; Taylor MD; Cho YJ; Pfister SM; Kool M; Korshunov A; Swartling FJ; Sangfelt O
    EMBO J; 2016 Oct; 35(20):2192-2212. PubMed ID: 27625374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of FBXW7 in Gynecologic Malignancies.
    Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
    Cells; 2023 May; 12(10):. PubMed ID: 37408248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation.
    Kumar Y; Kapoor I; Khan K; Thacker G; Khan MP; Shukla N; Kanaujiya JK; Sanyal S; Chattopadhyay N; Trivedi AK
    J Biol Chem; 2015 Dec; 290(52):30975-87. PubMed ID: 26542806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.
    Davis RJ; Welcker M; Clurman BE
    Cancer Cell; 2014 Oct; 26(4):455-64. PubMed ID: 25314076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An innate pathogen sensing strategy involving ubiquitination of bacterial surface proteins.
    Apte S; Bhutda S; Ghosh S; Sharma K; Barton TE; Dibyachintan S; Sahay O; Roy S; Sinha AR; Adicherla H; Rakshit J; Tang S; Datey A; Santra S; Joseph J; Sasidharan S; Hammerschmidt S; Chakravortty D; Oggioni MR; Santra MK; Neill DR; Banerjee A
    Sci Adv; 2023 Mar; 9(12):eade1851. PubMed ID: 36947610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
    Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.